Simcere Pharmaceutical Group Announces Sale of Equity Interest in Boda

    Simcere Pharmaceutical Group Announces Sale of Equity Interest in Boda

PR Newswire

NANJING, China, June 24, 2013

NANJING, China, June 24, 2013 /PRNewswire/ --Simcere Pharmaceutical Group
("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company
specializing in the development, manufacturing, and marketing of branded and
proprietary pharmaceuticals in China, today announced that it entered into a
share transfer agreement with Zhuhai Rongding Equity Investment Partnership
L.P. on June 17, 2013 to sell Simcere's approximately 99.99% equity interest
in Jilin Boda pharmaceutical Co., Ltd. ("Boda"), which is currently the
manufacturer of Yidasheng, for a cash consideration of RMB400 million.

Simcere holds an approximately 99.99% stake in Boda through acquisitions made
since 2007. Upon completion of this transaction, Simcere will no longer hold
any equity interest in Boda. Consummation of the transaction is subject to
certain closing conditions.

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR) is a
leading pharmaceutical company specializing in the development, manufacturing,
and marketing of branded and proprietary pharmaceuticals in China. Simcere
concentrates its research and development efforts on the treatment of diseases
with high incidence and/or mortality rates and for which there is a clear
demand for more effective pharmacotherapy such as cancer, strokes,
cardiovascular disease, infectious diseases and pain. For more information
about Simcere Pharmaceutical Group, please visit www.simcere.com.

Investor and Media Contacts:

Email: ir@simcere.com

In Nanjing:                  In the United States:

Jie Liu D'Elia               Cindy Zheng

Vice President               Brunswick Group LLC

Simcere Pharmaceutical Group Tel: 1-212-333-3810

Tel: 86-25-8556-6666*8857    
In Beijing:

Yue Yu

Brunswick Group

Tel: 86-10-5960-8600

SOURCE Simcere Pharmaceutical Group

Website: http://www.simcere.com